|
⚲
|
| Keyboard |
| Kowalsky Matthew Paul
✚
|
|
|---|---|
| CIK # | 0001705824 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001705824] | |
| 4 | [0001705824] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kowalsky Matthew Paul | |
| Enanta Pharmaceuticals Inc | |
| Sigilon Therapeutics Inc | |
| Proteon Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Enanta Pharmaceuticals Inc ENTA
Common Stock
|
2026-02-12 | Tax withheld | 1,902 | $14.25 | 27,104 |
|
Enanta Pharmaceuticals Inc ENTA
Common Stock
|
2026-02-12 | Grant | 1,318 | $0.00 | |
|
Enanta Pharmaceuticals Inc ENTA
Common Stock
|
2026-02-12 | Grant | 4,175 | $0.00 | |
|
Enanta Pharmaceuticals Inc ENTA
Stock Option (right to buy) · derivative
|
2025-11-25 | Grant | 90,000 | $0.00 | |
|
Enanta Pharmaceuticals Inc ENTA
Stock Option (right to buy) · derivative
|
2024-11-27 | Grant | 75,000 | $0.00 | |
|
Enanta Pharmaceuticals Inc ENTA
Stock Option (right to buy) · derivative
|
2024-04-29 | Grant | 150,000 | $0.00 | |
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-08-11 | Disposed to issuer | 12,690 | $0.75 | 9,518 |
|
Sigilon Therapeutics Inc SGTX
Common Stock
|
2023-08-11 | Disposed to issuer | 1,925 | ||
|
Sigilon Therapeutics Inc SGTX
Stock Option (Right to Buy) · derivative
|
2023-02-28 | Grant | 165,000 | $0.00 | |
|
Proteon Therapeutics Inc PRTO
Stock Option (Right to Buy) · derivative
|
2019-01-18 | Grant | 60,000 | $0.00 | |
|
Proteon Therapeutics Inc PRTO
Common Stock
|
2018-12-31 | Grant | 2,448 | $1.93 | 4,725 |
|
Proteon Therapeutics Inc PRTO
Common Stock
|
2018-06-29 | Grant | 10,000 | $1.62 | 16,200 |
|
Proteon Therapeutics Inc PRTO
Stock Option (Right to Buy) · derivative
|
2018-01-17 | Grant | 110,000 | $0.00 | |
|
Proteon Therapeutics Inc PRTO
Common Stock
|
2017-12-29 | Grant | 3,934 | $1.30 | 5,114 |
|
Proteon Therapeutics Inc PRTO
Common Stock
|
2017-06-30 | Grant | 10,000 | $1.30 | 13,000 |